Kenneth A. Lock Arcutis Biotherapeutics, Inc. (ARQT) insider trading activity

ARQT Quotes by TradingView

Kenneth A. Lock is Chief Commercial Officer of Arcutis Biotherapeutics, Inc.. Currently has a direct ownership of 63,429 shares of ARQT, which is worth approximately $589,889. The most recent transaction as insider was on Mar 06, 2023, when has been sold 831 shares (Common Stock) at a price of $15.26 per share, resulting in proceeds of $12,681. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.4K
0% 3M change
0% 12M change
Total Value Held $589,889

Kenneth A. Lock Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2023
SELL
Open market or private sale
$12,681 $15.26 p/Share
831 Reduced 1.29%
63,429 Common Stock
Mar 02 2023
SELL
Open market or private sale
$23,155 $16.17 p/Share
1,432 Reduced 3.2%
43,260 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
21,000 Added 24.63%
64,260 Common Stock
Feb 28 2023
SELL
Open market or private sale
$15,135 $16.17 p/Share
936 Reduced 2.05%
44,692 Common Stock
Mar 07 2022
SELL
Open market or private sale
$493 $16.44 p/Share
30 Reduced 0.07%
44,011 Common Stock
Mar 04 2022
SELL
Open market or private sale
$16,742 $16.86 p/Share
993 Reduced 2.21%
44,041 Common Stock
Mar 03 2022
BUY
Grant, award, or other acquisition
-
13,300 Added 22.8%
45,034 Common Stock
Mar 01 2022
SELL
Open market or private sale
$16,596 $17.75 p/Share
935 Reduced 2.86%
31,734 Common Stock
Mar 03 2021
BUY
Grant, award, or other acquisition
-
9,500 Added 23.08%
31,667 Common Stock
Mar 01 2021
SELL
Open market or private sale
$31,909 $34.2 p/Share
933 Reduced 4.04%
22,167 Common Stock
Oct 26 2020
BUY
Exercise of conversion of derivative security
$17,395 $6.52 p/Share
2,668 Added 10.88%
21,863 Common Stock
Oct 22 2020
BUY
Exercise of conversion of derivative security
$17,571 $6.52 p/Share
2,695 Added 12.31%
19,195 Common Stock
Oct 15 2020
BUY
Exercise of conversion of derivative security
$48,900 $6.52 p/Share
7,500 Added 31.25%
16,500 Common Stock
KAL

Kenneth A. Lock

Chief Commercial Officer
Westlake Village, CA

Track Institutional and Insider Activities on ARQT

Follow Arcutis Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARQT shares.

Notify only if

Insider Trading

Get notified when an Arcutis Biotherapeutics, Inc. insider buys or sells ARQT shares.

Notify only if

News

Receive news related to Arcutis Biotherapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARQT